Tags · Sourcing
Medutest
Independent testing and verification service.
Related in this group: certificate of analysis · batch & lot numbers · Janoshik Analytical · PeptideMeter · VendorInvestigate · third-party testing · blind sampling · documentation quality · underdosing · mislabelling · customs · shipping
21 topics
| Topic | Participants | Replies | Views | Activity |
|---|---|---|---|---|
|
Aggregate verification data across the directory, with caveats
On the subject in the title: Aggregate verification data across the directory, with caveats Working notes rather than a conclusion. Structured report rather than an opinion, following the format the…
|
+64 | 74 | 4.6k | 14h |
|
Chain of custody for a sample you posted yourself — one year on
Posting this under the heading it deserves: Chain of custody for a sample you posted yourself — one year on Everything below is what sits behind that. Structured report rather than an opinion, following the…
|
+28 | 32 | 50k | 15h |
|
[2026 update] Interpreting a result that disagrees with the supplier's certificate
On the subject in the title: Interpreting a result that disagrees with the supplier's certificate Working notes rather than a conclusion. Structured report rather than an opinion, following the format the…
|
+121 | 128 | 51k | 17h |
|
Submitting a sample: the process end to end
On the subject in the title: Submitting a sample: the process end to end Working notes rather than a conclusion. I would like to talk about documentation quality as a signal, separately from product quality.…
|
+99 | 114 | 29k | 21h |
|
About the Independent verification category
Janoshik, Medutest, PeptideMeter and VendorInvestigate results, how to submit a sample, and how to read what comes back. This post is a community wiki: any member at trust level 3 or above can edit it, and…
|
+1 | 5 | 5.8k | 23h |
|
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ — does this still hold?
Asking directly, because I could not find a straight answer: How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ — does this still hold? Structured report rather than an opinion, following the…
|
+24 | 28 | 8k | 1mo |
|
Blind submission and why it changes minds — the long version
Posting this under the heading it deserves: Blind submission and why it changes minds — the long version Everything below is what sits behind that. Structured report rather than an opinion, following the…
|
+98 | 113 | 18k | 2mo |
|
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ — a second dataset
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ — a second dataset I have a specific reason for asking rather than idle curiosity, and the context is below. A logistics question, since the…
|
+42 | 46 | 46k | 2mo |
|
Turnaround times and what they mean for a decision
Turnaround times and what they mean for a decision Writing it up because I had to work it out twice and would rather nobody else did. A logistics question, since the answers here are usually better than…
|
4 | 29k | 3mo | |
|
Choosing which test to pay for, given a fixed budget
On the subject in the title: Choosing which test to pay for, given a fixed budget Working notes rather than a conclusion. I would like to talk about documentation quality as a signal, separately from product…
|
+60 | 70 | 49k | 3mo |
|
Second pass at: Submitting a sample: the process end to end
Second pass at: Submitting a sample: the process end to end Writing it up because I had to work it out twice and would rather nobody else did. A logistics question, since the answers here are usually better…
|
+12 | 16 | 41k | 4mo |
|
Interpreting a result that disagrees with the supplier's certificate
Interpreting a result that disagrees with the supplier's certificate Writing it up because I had to work it out twice and would rather nobody else did. Structured report rather than an opinion, following the…
|
+129 | 153 | 7.3k | 5mo |
|
Publishing an inconvenient result: a case study — the long version
Publishing an inconvenient result: a case study — the long version Writing it up because I had to work it out twice and would rather nobody else did. Structured report rather than an opinion, following the…
|
+68 | 74 | 12k | 7mo |
|
What a purity-only report leaves out
What a purity-only report leaves out — that is the question, and I have not found it answered plainly anywhere I have looked. Structured report rather than an opinion, following the format the maintainers…
|
+92 | 105 | 4k | 8mo |
|
Publishing an inconvenient result: a case study
On the subject in the title: Publishing an inconvenient result: a case study Working notes rather than a conclusion. Structured report rather than an opinion, following the format the maintainers asked for.…
|
+59 | 70 | 992 | 11mo |
|
What a documentation review can and cannot tell you
What a documentation review can and cannot tell you — that is the question, and I have not found it answered plainly anywhere I have looked. I would like to talk about documentation quality as a signal,…
|
+79 | 83 | 950 | 11mo |
|
Splitting a vial for two laboratories: how to do it without ruining both
Splitting a vial for two laboratories: how to do it without ruining both — setting out what I have, and where I think it stops being reliable. A logistics question, since the answers here are usually better…
|
+64 | 70 | 4.4k | 13mo |
|
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ I have a specific reason for asking rather than idle curiosity, and the context is below. Structured report rather than an opinion, following…
|
+117 | 130 | 3.3k | 14mo |
|
Revisiting: Aggregate verification data across the directory, with caveats
Revisiting: Aggregate verification data across the directory, with caveats — setting out what I have, and where I think it stops being reliable. I would like to talk about documentation quality as a signal,…
|
+22 | 26 | 23k | 17mo |
|
Turnaround times and what they mean for a decision — one year on
On the subject in the title: Turnaround times and what they mean for a decision — one year on Working notes rather than a conclusion. Structured report rather than an opinion, following the format the…
|
+25 | 29 | 22k | 18mo |
|
Splitting a vial for two laboratories: how to do it without ruining both — what changed since
Posting this under the heading it deserves: Splitting a vial for two laboratories: how to do it without ruining both — what changed since Everything below is what sits behind that. A logistics question, since…
|
+107 | 115 | 5.2k | 22mo |